2021
DOI: 10.1016/j.mmcr.2021.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Prototheca wickerhamii breast implant infection after reconstructive surgery: a new level of complexity

Abstract: We report the first published case of Prototheca wickerhamii breast implant infection. This occurred after mastectomy, chemotherapy, radiotherapy, breast reconstruction, implant revisions and breast seroma aspirations and was preceded by polymicrobial infection. Definitive treatment required implant removal and intravenous liposomal amphotericin B. The management of breast prosthesis infections is discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…Amphotericin B is currently the first-line treatment in disseminated cases and in patients with severe underlying diseases or immunosuppression. 6 , 7 , 8 , 9 …”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Amphotericin B is currently the first-line treatment in disseminated cases and in patients with severe underlying diseases or immunosuppression. 6 , 7 , 8 , 9 …”
mentioning
confidence: 99%
“…The initiation of adequate treatment prevents the progression of the disease. 5 , 6 , 7 , 8 , 9 , 10 …”
mentioning
confidence: 99%